Navigation Links
The Lancet Publication Of LAPLACE-TIMI 57 And MENDEL Studies Showed AMG 145 Significantly Reduced LDL Cholesterol
Date:11/6/2012

LDL receptors in the liver. Without PCSK9 bound to them, the LDL receptors can take up and remove LDL-C from the blood, recycle and remain available for binding additional LDL-C. The Amgen Phase 2 program for AMG 145 enrolled more than 2,000 patients across seven studies to evaluate the effects of AMG 145 across multiple patient populations who may benefit from additional cholesterol lowering treatment options. The Phase 2 program is evaluating the treatment of hyperlipidemia with AMG 145 in combination with statins, in patients with hyperlipidemia who cannot tolerate statins, as a stand-alone treatment in patients with hyperlipidemia, and in patients whose elevated cholesterol is caused by genetic disorders called heterozygous and homozygous familial hypercholesterolemia.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.

Forward-Looking Statements
This news release contains forward-looking statements that are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described. All statements, other than statements of historical fact
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Results For Phase 2b Trial Of Unique Investigational Cell-Based Therapy In Venous Leg Ulcers Published In The Lancet
2. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
3. Cardiac Dimensions® Announces Publication of TITAN Clinical Trial Data in European Journal of Heart Failure
4. Aethlon Medical (AEMD) Note: Cancer Treatment Publication Authored by Aethlon Medical Researchers Now Available
5. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
6. Publication of PrEP Trial Data Provides Clear Evidence that PrEP Works for Men and Women
7. Amsterdam Molecular Therapeutics (AMT) Holding N.V. (in liquidation) Announces Publication of its Accounts for 2011 and Notice of Annual General Meeting
8. ESTEVE Announces Publication of Key Preclinical Data for a Novel Oral, First-in-class New Chemical Entity (NCE) Sigma-1 Receptor Antagonist (E-52862), that has Completed Phase I and Initiated its Phase II Clinical Trial Program
9. Avanir Pharmaceuticals Announces Publication Of PBA Burden Of Illness Study
10. International Spine Products Manufacturer Featured in Upcoming US Business Executive Publication - www.gsmedicalusa.com
11. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)...  PuraMed BioScience®, Inc., (OTCBB: PMBS), a researcher, ... healthcare products, announced today that the company is ... "We are pleased to sponsor Operation Troop ... Chairman of PuraMed BioScience. "Research shows that many ... migraines much more frequently than the general population. ...
(Date:7/22/2014)... -- Neurotrope Bioscience, Inc., a subsidiary of Neurotrope, Inc. (OTCQB: ... the Icahn School of Medicine at Mount ... to utilize its proprietary information and data package for ... Type C Disease (NPC), a rare disease, mostly of ... also covers other diseases and disorders relying on activation ...
(Date:7/22/2014)... -- According to the American Optometric Association (AOA), parents severely ... An AOA survey reports that 83 percent of children ... use an electronic device for three or more hours ... revealed that only 40 percent of parents believe their ... of time. Eye doctors are concerned that this significant ...
Breaking Medicine Technology:PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 2PuraMed BioScience Partners with Operation Troop Aid to Sponsor Care Packages 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4
... Colo., May 13, 2011 Mesa Laboratories, Inc. (NASDAQ: ... of Directors has declared a regular quarterly cash dividend ... on June 15, 2011 to shareholders of record at ... Mesa Laboratories develops, acquires, manufactures and markets electronic ...
... Cookeville-based Aphena Pharma Solutions Inc., a leading pharmaceutical ... that on June 1, Mary G. Foster, PharmD — one ... join the company as its Corp. VP of Quality and ... shape its vision, plan long-term goals, and further enhance the ...
Cached Medicine Technology:Top Industry Professional Joins Aphena as Head of Quality & Regulatory Affairs 2
(Date:7/22/2014)... Brand journalism tactics for ... Ragan Communications 2014 Health Care PR and Marketing ... consecutive year that MediaSource placed in the finalist category ... the winning MediaSource team last year. This year the ... against three other contenders that include AMF Media Group ...
(Date:7/22/2014)... HealthDay Reporter , MONDAY, July 21, 2014 (HealthDay ... high school may take fewer health risks than their peers ... of low-income Los Angeles teens, found that those who attended ... binge-drink, have multiple sex partners or take certain other health ... kids" being more likely to go to good schools, researchers ...
(Date:7/22/2014)... team has identified protein "signatures" of genetic mutations ... cause of cancer deaths after lung cancer. , ... current issue of the journal Nature ... cancer, "will enable new advances" in diagnosing and ... a first-of-its-kind paper. I think it,s a very ...
(Date:7/22/2014)... July 22, 2014 SkillSurvey Inc., ... that help employers make better hiring decisions, will ... to improve the engagement and retention of contingent ... Recruitment’s IMAGE 2014 Conference being held in Orlando, ... include a case study featuring Metro Health, a ...
(Date:7/22/2014)... 2014 The purpose of this ... specific market segment called disposable medical supplies. Disposable ... global healthcare equipment and supplies sector. The disposable ... syringes, disposable medical catheters, wound care products, isolation ... products, blood glucose test strips, lancets, lancing devices, ...
Breaking Medicine News(10 mins):Health News:MediaSource Brand Journalism Returns to Best Health Care Agency Competition in Ragan Communications Health Care Awards 2Health News:MediaSource Brand Journalism Returns to Best Health Care Agency Competition in Ragan Communications Health Care Awards 3Health News:Good Schools May Be Good for a Teen's Health, Too 2Health News:Good Schools May Be Good for a Teen's Health, Too 3Health News:Vanderbilt discovery may advance colorectal cancer diagnosis and treatment 2Health News:SkillSurvey to Present Research on Contingent Workers at National Association for Health Care Recruitment IMAGE 2014 Conference 2Health News:Growth of Disposable Medical Supplies Market to 2019 Report Available at RnRMarketResearch.com 2Health News:Growth of Disposable Medical Supplies Market to 2019 Report Available at RnRMarketResearch.com 3Health News:Growth of Disposable Medical Supplies Market to 2019 Report Available at RnRMarketResearch.com 4Health News:Growth of Disposable Medical Supplies Market to 2019 Report Available at RnRMarketResearch.com 5
... areas of B.C. are up to twice as likely ... better-off areas, a University of British Columbia study has ... online journal Public Library of Science ONE , ... are more vulnerable to death from chronic disease, particularly ...
... N.Y., Jan. 8 Davis Vision, Inc., headquartered in ... of sales for its Northern division. In this new ... Davis Vision,s national new business development. "Mike will be ... said Tom Davis, Davis Vision,s executive vice president and ...
... Supplement Health and Education Act Mandates Label ... , WASHINGTON, Jan. 8 In response ... supplement regulation, the Natural Products Association,s Executive ... statement:Increased scrutiny by professional sports leagues on ...
... illness can lead to poorer quality of lifeparticularly ... help teens cope with their conditions. , Two ... professor of medicine, and Sian Cotton, PhD, research ... investigated how adolescents with inflammatory bowel disease (IBD)a ...
... on pets during National Glaucoma month. , ... Tampa, ... Month, Florida Veterinary Specialists (FVS) are spreading the word ... as humans.    , , ,"When eyes go bad, they often do so ...
... much more likely to be deadly for women and African-Americans, ... for only part of the differences for such patients compared ... in the Jan. 1 issue of the journal Cancer ... If age, tumor type, and stage of the disease upon ...
Cached Medicine News:Health News:Mortality rates higher for heart disease patients in poorer B.C. neighborhoods 2Health News:Davis Vision, Inc. Names Michael Ehrle Divisional Vice President of Sales 2Health News:Natural Products Association Advocates Strength of Dietary Supplement Law 2Health News:Spirituality may help adolescents cope with chronic illness 2Health News:Spirituality may help adolescents cope with chronic illness 3Health News:Glaucoma Awareness Not Just for Humans 2Health News:Glaucoma Awareness Not Just for Humans 3Health News:Why Bladder Cancer Is Deadlier for Some 2Health News:Why Bladder Cancer Is Deadlier for Some 3Health News:Why Bladder Cancer Is Deadlier for Some 4
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
96-Well PCR Plate Sealing Mat...
Inquire...
Inquire...
Medicine Products: